Author Otto, Markus
-
2000 | Journal Article
Decreased beta-amyloid(1-42) in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Otto, M.; Esselmann, H. ; Schulz-Schaeffer, W. J.; Neumann, M.; Schroter, A.; Ratzka, P. & Cepek, L. et al. (2000)
Neurology, 54(5) pp. 1099-1102.
Details PMID PMC WoS
-
2000 | Journal Article
Stochastic relaxational dynamics applied to finance: Towards non-equilibrium option pricing theory
Otto, M. (2000)
The European Physical Journal B, 14(2) pp. 383-394. DOI: https://doi.org/10.1007/s100510050143
Details DOI WoS
-
2001 | Journal Article
The direct link model for polymer rings using topological field theory and the second topological moment in dense systems
Otto, M. (2001)
JOURNAL OF PHYSICS A-MATHEMATICAL AND GENERAL, 34(12) pp. 2539-2547. DOI: https://doi.org/10.1088/0305-4470/34/12/302
Details DOI WoS
-
2001 | Journal Article
Reporting cerebrospinal fluid data: Knowledge base and interpretation software
Reiber, H.; Otto, M.; Trendelenburg, C. & Wormek, A. (2001)
Clinical Chemistry and Laboratory Medicine (CCLM), 39(4) pp. 324-332. DOI: https://doi.org/10.1515/CCLM.2001.051
Details DOI PMID PMC WoS
-
2002 | Conference Abstract
Primary cell culture of chicken telencephalon: A model to study the catabolic processing of endogenous amyloid precursor protein and abeta peptides
Esselmann, H.; Kunz, N.; Smirnov, A.; Paul, S.; Dombek, M.; Ruether, E. & Wiltfang, J. et al. (2002)
Neurobiology of Aging, 23(1)
New york: Elsevier Science Inc.
Details WoS
-
2002 | Conference Abstract
The phospho-tau/total-tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias
Riemenschneider, M.; Forstl, H.; Kurz, A.; Wagenpfeil, S.; Vanderstichele, H.; Otto, M. & Wiltfang, J. et al. (2002)
Neurobiology of Aging, 23(1) pp. S274-S275.
New york: Elsevier Science Inc.
Details WoS
-
2002 | Conference Abstract
Highly conserved and disease-specific patterns of carboxyterminally truncated abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation
Wiltfang, J.; Esselmann, H.; Bibl, M.; Smirnov, A.; Paul, S.; Ruether, E. & Otto, M. et al. (2002)
Neurobiology of Aging, 23(1)
New york: Elsevier Science Inc.
Details WoS
-
2002 | Conference Abstract
Efficacy of flupirtine on cognitive function in patients with Creutzfeldt-Jakob-disease
Otto, M.; Ratzka, P.; Doehlinger, S.; Boekhoff, I.; Poser, S.; Prange, H. & Wiltfang, J. et al. (2002)
Neurobiology of Aging, 23(1) pp. S131-S132.
New york: Elsevier Science Inc.
Details WoS
-
2002 | Journal Article
New aspects in the histological examination of polyethylene wear particles in failed total joint replacements
Hansen, T. C.; Otto, M.; Buchhorn, G. H.; Scharnweber, D.; Gaumann, A.; Delank, K. S. & Eckardt, A. et al. (2002)
Acta Histochemica, 104(3) pp. 263-269. DOI: https://doi.org/10.1078/0065-1281-00649
Details DOI PMID PMC WoS
-
2002 | Journal Article
Serum tau protein level as a marker of axonal damage in acute ischemic stroke
Bitsch, A.; Horn, C.; Kemmling, Y. ; Seipelt, M.; Hellenbrand, U.; Stiefel, M. & Ciesielczyk, B. et al. (2002)
European Neurology, 47(1) pp. 45-51. DOI: https://doi.org/10.1159/000047946
Details DOI PMID PMC WoS
-
2002 | Journal Article
A beta peptide(1-42), Tau protein and S-100B protein level in cerebrospinal fluid of three patients with primary progressive aphasia
Otto, M.; Stoppe, G.; Maeck, L. ; Meller, J. ; Stiens, G. & Wiltfang, J. (2002)
Neuroscience Letters, 333(1) art. PII S0304-3940(02)00968-0. DOI: https://doi.org/10.1016/S0304-3940(02)00968-0
Details DOI PMID PMC WoS
-
2003 | Review
Sports and mild traumatic brain injury
Holzgraefe, M.& Otto, M. (2003)
AKTUELLE NEUROLOGIE, 30(10) pp. 519-524.
Georg Thieme Verlag Kg. DOI: https://doi.org/10.1055/s-2003-45014
Details DOI WoS
-
2003 | Conference Paper
Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease
Otto, M. & Wiltfang, J. (2003)
Restorative Neurology and Neuroscience, 21(3-4) pp. 191-209. International Symposium on Molecular Markers of Brain Damage - Current State and Future Perspectives, BREMEN, GERMANY.
Amsterdam: Ios Press.
Details PMID PMC WoS
-
2003 | Journal Article | Letter Note
Diagnostic problems during late course in Creutzfeldt-Jakob disease
Mollenhauer, B.; Serafin, S.; Zerr, I.; Steinhoff, B. J.; Otto, M.; Scherer, M. & Schulz-Schaeffer, W. J. et al. (2003)
Journal of Neurology, 250(5) pp. 629-630. DOI: https://doi.org/10.1007/s00415-003-1059-3
Details DOI PMID PMC WoS
-
2003 | Journal Article
Anisotropy in granular media: Classical elasticity and directed-force chain network
Otto, M.; Bouchaud, J. P.; Claudin, P. & Socolar, J. (2003)
PHYSICAL REVIEW E, 67(3) art. 031302. DOI: https://doi.org/10.1103/PhysRevE.67.031302
Details DOI PMID PMC WoS
-
2003 | Journal Article
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias
Riemenschneider, M.; Wagenpfeil, S.; Vanderstichele, H.; Otto, M.; Wiltfang, J.; Kretzschmar, H. A. & Vanmechelen, E. et al. (2003)
Molecular Psychiatry, 8(3) pp. 343-347. DOI: https://doi.org/10.1038/sj.mp.4001220
Details DOI PMID PMC WoS
-
2003 | Journal Article
Different binding pattern of antibodies to prion protein on lymphocytes from patients with sporadic Creutzfeldt–Jakob disease
Ratzka, P.; Döhlinger, S.; Cepek, L.; Steinacker, P.; Arlt, S.; Jacobi, C. & Schröter, A. et al. (2003)
Neuroscience Letters, 343(1) pp. 29-32. DOI: https://doi.org/10.1016/S0304-3940(03)00315-X
Details DOI PMID PMC WoS
-
2003 | Journal Article
beta-Amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Wiltfang, J.; Esselmann, H.; Smirnov, A.; Bibl, M.; Cepek, L.; Steinacker, P. & Mollenhauer, B. et al. (2003)
Annals of Neurology, 54(2) pp. 263-267. DOI: https://doi.org/10.1002/ana.10661
Details DOI PMID PMC WoS
-
2003 | Journal Article
The amyloid-beta (A beta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated A beta peptide
Lewczuk, P.; Esselmann, H.; Meyer, M.; Wollscheid, V.; Neumann, M.; Otto, M. & Maler, J. M. et al. (2003)
Rapid Communications in Mass Spectrometry, 17(12) pp. 1291-1296. DOI: https://doi.org/10.1002/rcm.1048
Details DOI PMID PMC WoS
-
2004 | Conference Abstract
Surface enhanced laser desorption/ionization time-of-flight mass spectrometry for the differential diagnosis of Creutzfeldt-Jakob disease
Steinacker, P.; Cepek, L.; Esselmann, H.; Kretzschmar, H. A.; Lewczuk, P.; Poser, S. & Wiltfang, J. et al. (2004)
Neurobiology of Aging, 25 pp. S34-S35. 9th International Conference on Alzheimers Disease and Related Disorders, Philadelphia, PA.
New york: Elsevier Science Inc. DOI: https://doi.org/10.1016/S0197-4580(04)80115-5
Details DOI WoS
-
2004 | Conference Abstract
Cerebrospinal fluid investigations in Creutzfeldt-Jakob disease
Zerr, I.; Heinemann, U.; Varges, D. A.; Stoeck, K.; Bartl, M. & Otto, M. (2004)
Neurobiology of Aging, 25 9th International Conference on Alzheimers Disease and Related Disorders, Philadelphia, PA.
New york: Elsevier Science Inc. DOI: https://doi.org/10.1016/S0197-4580(04)81526-4
Details DOI WoS
-
2004 | Journal Article
Topological interactions in systems of mutually interlinked polymer rings
Otto, M. (2004)
JOURNAL OF PHYSICS A-MATHEMATICAL AND GENERAL, 37(8) pp. 2881-2893. DOI: https://doi.org/10.1088/0305-4470/37/8/003
Details DOI WoS
-
2004 | Journal Article
Local equation of state and velocity distributions of a driven granular gas
Herbst, O.; Mueller, P.; Otto, M. & Zippelius, A. (2004)
Physical Review. E, 70(5) art. 051313. DOI: https://doi.org/10.1103/PhysRevE.70.051313
Details DOI PMID PMC WoS
-
2004 | Journal Article
Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases
Steinacker, P.; Mollenhauer, B.; Bibl, M.; Cepek, L.; Esselmann, H.; Brechlin, P. & Lewczuk, P. et al. (2004)
Neuroscience Letters, 370(1) pp. 36-39. DOI: https://doi.org/10.1016/j.neulet.2004.07.061
Details DOI PMID PMC WoS
-
2004 | Journal Article
Role of interleukin-1 in prion disease-associated astrocyte activation
Schultz, J.; Schwarz, A.; Neidhold, S.; Burwinkel, M.; Riemer, C.; Simon, D. & Kopf, M. et al. (2004)
American Journal Of Pathology, 165(2) pp. 671-678. DOI: https://doi.org/10.1016/S0002-9440(10)63331-7
Details DOI PMID PMC WoS
-
2004 | Conference Paper
Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease - Original data and review of the literature
Lewczuk, P.; Esselmann, H.; Bibl, M.; Beck, G.; Maler, J. M.; Otto, M. & Kornhuber, J. et al. (2004)
Journal of Molecular Neuroscience, 23(1-2) pp. 115-122. Symposium on Novel Therapeutic Opportunities for Neuodegenerative Disease, Univ Aveiro, Aveiro, PORTUGAL.
Totowa: Humana Press Inc. DOI: https://doi.org/10.1385/JMN:23:1-2:115
Details DOI PMID PMC WoS
-
2004 | Journal Article
CSF lactate dehydrogenase activity in patients with Creutzfeldt-Jakob disease exceeds that in other dementias
Schmidt, H.; Otto, M.; Niedmann, P. ; Cepek, L.; Schroter, A.; Kretzschmar, H. A. & Poser, S. (2004)
Dementia and Geriatric Cognitive Disorders, 17(3) pp. 204-206. DOI: https://doi.org/10.1159/000076357
Details DOI PMID PMC WoS
-
2004 | Journal Article
Neurochemical diagnosis of Alzheimer's dementia by CSF A beta 42, A beta 42/A beta 40 ratio and total tau
Lewczuk, P.; Otto, M.; Maler, J. M.; Reulbach, U.; Kornhuber, J.; Esselmann, H. & Henkel, A. W. et al. (2004)
Neurobiology of Aging, 25(3) pp. 273-281. DOI: https://doi.org/10.1016/S0197-4580(03)00086-1
Details DOI PMID PMC WoS
-
2004 | Journal Article
Value of CSF beta-amyloid(1-42) and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment
Hampel, H.; Teipel, S. J.; Fuchsberger, T.; Andreasen, N.; Wiltfang, J.; Otto, M. & Shen, Y. et al. (2004)
Molecular Psychiatry, 9(7) pp. 705-710. DOI: https://doi.org/10.1038/sj.mp.4001473
Details DOI PMID PMC WoS
-
2005 | Journal Article
Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease
Mollenhauer, B.; Bibl, M.; Trenkwalder, C.; Stiens, G.; Cepek, L.; Steinacker, P. & Ciesielczyk, B. et al. (2005)
Journal of Neural Transmission, 112(7) pp. 933-948. DOI: https://doi.org/10.1007/s00702-004-0235-7
Details DOI PMID PMC WoS
-
2005 | Journal Article
Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Cepek, L.; Steinacker, P.; Mollenhauer, B.; Wiese, B.; Ciesielczyk, B.; Bibl, M. & Wiltfang, J. et al. (2005)
Dementia and Geriatric Cognitive Disorders, 19(5-6) pp. 376-382. DOI: https://doi.org/10.1159/000084708
Details DOI PMID PMC WoS
-
2005 | Journal Article
Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease
Meier, A.; Mollenhauer, B.; Cohrs, S.; Rodenbeck, A.; Jordan, W.; Meller, J. & Otto, M. (2005)
Brain Research, 1063(2) pp. 201-203. DOI: https://doi.org/10.1016/j.brainres.2005.09.028
Details DOI PMID PMC WoS
-
2005 | Journal Article
Creutzfeldt-Jakob disease and homocysteine levels in plasma and cerebrospinal fluid
Bleich, S.; Otto, M.; Zerr, I.; Kropp, S.; Kretzschmar, H. A. & Wiltfang, J. (2005)
Gerontology, 51(2) pp. 142-144. DOI: https://doi.org/10.1159/000082200
Details DOI PMID PMC WoS
-
2005 | Review
Consensus paper of the WFSBP Task Force on biological markers of dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia
Wiltfang, J.; Lewczuk, P.; Riederer, P.; Grunblatt, E.; Hock, C.; Scheltens, P.& Hampel, H. et al. (2005)
The World Journal of Biological Psychiatry, 6(2) pp. 69-84.
Taylor & Francis Ltd. DOI: https://doi.org/10.1080/15622970510029786
Details DOI PMID PMC WoS
-
2006 | Journal Article
Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies
Mollenhauer, B.; Bibl, M.; Wiltfang, J.; Steinacker, P.; Ciesielczyk, B.; Neubert, K. & Trenkwalder, C. et al. (2006)
Clinical Chemistry and Laboratory Medicine (CCLM), 44(2) pp. 192-195. DOI: https://doi.org/10.1515/CCLM.2006.035
Details DOI PMID PMC WoS
-
2006 | Journal Article
International quality control survey of neurochemical dementia diagnostics
Lewczuk, P.; Beck, G.; Ganslandt, O.; Esselmann, H.; Deisenhammer, F.; Regeniter, A. & Petereit, H.-F. et al. (2006)
Neuroscience Letters, 409(1) pp. 1-4. DOI: https://doi.org/10.1016/j.neulet.2006.07.009
Details DOI PMID PMC WoS
-
2006 | Journal Article
Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia
Mollenhauer, B.; Trenkwalder, C.; von Ahsen, N.; Bibl, M.; Steinacker, P.; Brechlin, P. & Schindehuette, J. et al. (2006)
Dementia and Geriatric Cognitive Disorders, 22(3) pp. 200-208. DOI: https://doi.org/10.1159/000094871
Details DOI PMID PMC WoS
-
2006 | Journal Article | Letter Note
Selective reduction of amyloid beta 42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation
Mollenhauer, B.; Bibl, M.; Esselmann, H.; Steinacker, P.; Trenkwalder, C.; Brechlin, P. & Wiltfang, J. et al. (2006)
Journal of Neurology Neurosurgery & Psychiatry, 77(10) pp. 1201-1203. DOI: https://doi.org/10.1136/jnnp.2005.084673
Details DOI PMID PMC WoS
-
2006 | Journal Article
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies
Bibl, M.; Mollenhauer, B.; Esselmann, H.; Lewczuk, P.; Trenkwalder, C.; Brechlin, P. & Ruether, E. et al. (2006)
Journal of Neural Transmission, 113(11) pp. 1771-1778. DOI: https://doi.org/10.1007/s00702-006-0537-z
Details DOI PMID PMC WoS
-
2006 | Journal Article
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
Bibl, M.; Mollenhauer, B.; Esselmann, H.; Lewczuk, P.; Klafki, H. W.; Sparbier, K. & Smirnov, A. et al. (2006)
Brain, 129 pp. 1177-1187. DOI: https://doi.org/10.1093/brain/awl063
Details DOI PMID PMC WoS
-
2007 | Journal Article
Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias
Bibl, M.; Mollenhauer, B.; Lewczuk, P.; Esselmann, H.; Wolf, S.; Trenkwalder, C. & Otto, M. et al. (2007)
Molecular Psychiatry, 12(7) pp. 671-680. DOI: https://doi.org/10.1038/sj.mp.4001967
Details DOI PMID PMC WoS
-
2007 | Journal Article
Blood-based neurochemical diagnosis of vascular dementia: A pilot study
Bibl, M.; Esselmann, H.; Mollenhauer, B.; Weniger, G.; Welge, V.; Liess, M. & Lewczuk, P. et al. (2007)
Journal of Neurochemistry, 103(2) pp. 467-474. DOI: https://doi.org/10.1111/j.1471-4159.2007.04763.x
Details DOI PMID PMC WoS
-
2007 | Journal Article
Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: Marker candidates for dementia with Lewy bodies
Mollenhauer, B.; Steinacker, P.; Bahn, E.; Bibl, M.; Brechlin, P.; Schlossmacher, M. G. & Locascio, J. J. et al. (2007)
Neurodegenerative Diseases, 4(5) pp. 366-375. DOI: https://doi.org/10.1159/000105157
Details DOI PMID PMC WoS
-
2007 | Journal Article
Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Cepek, L.; Brechlin, P.; Steinacker, P.; Mollenhauer, B.; Klingebiel, E.; Bibl, M. & Kretzschmar, H. A. et al. (2007)
Dementia and Geriatric Cognitive Disorders, 23(1) pp. 22-28. DOI: https://doi.org/10.1159/000096589
Details DOI PMID PMC WoS
-
2007 | Journal Article
Tauopathies and synucleinopathies: Do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?
Mollenhauer, B.; Bibl, M.; Esselmann, H.; Steinacker, P.; Trenkwalder, C.; Wiltfang, J. & Otto, M. (2007)
Journal of Neural Transmission, 114(7) pp. 919-927. DOI: https://doi.org/10.1007/s00702-007-0629-4
Details DOI PMID PMC WoS
-
2008 | Journal Article
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study
Lewczuk, P.; Kornhuber, J.; Vanderstichele, H.; Vanmechelen, E.; Esselmann, H.; Bibl, M. & Wolf, S. et al. (2008)
Neurobiology of Aging, 29(6) pp. 812-818. DOI: https://doi.org/10.1016/j.neurobiolaging.2006.12.010
Details DOI PMID PMC WoS
-
2008 | Journal Article |
Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimer-typical A beta(42) reduces their differentiation potential
Uhrig, M.; Brechlin, P.; Jahn, O. ; Knyazev, Y.; Weninger, A.; Busia, L. & Honarnejad, K. et al. (2008)
BMC Medicine, 6 art. 38. DOI: https://doi.org/10.1186/1741-7015-6-38
Details DOI PMID PMC WoS
-
2008 | Journal Article
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease
Brechlin, P.; Jahn, O. ; Steinacker, P.; Cepek, L.; Kratzin, H.; Lehnert, S. & Jesse, S. et al. (2008)
Proteomics, 8(20) pp. 4357-4366. DOI: https://doi.org/10.1002/pmic.200800375
Details DOI PMID PMC WoS
-
2008 | Journal Article
CSF amyloid-beta 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction
Bibl, M.; Lewczuk, P.; Esselmann, H.; Mollenhauer, B.; Klafki, H.-W.; Welge, V. & Wolf, S. et al. (2008)
PROTEOMICS - CLINICAL APPLICATIONS, 2(10-11) pp. 1548-1556. DOI: https://doi.org/10.1002/prca.200800006
Details DOI PMID PMC WoS
-
2009 | Review
Consensus Paper of the WFSBP Task Force on Biological Markers of Dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia
Wiltfang, J.; Lewczuk, P.; Riederer, P.; Gruenblatt, E.; Hock, C.; Scheltens, P.& Hampel, H. et al. (2009)
REVISTA DE PSIQUIATRIA CLINICA, 36 pp. 1-16.
Univ Sao Paulo, Inst Psiquiatria.
Details WoS